Social-first activation across EMEA

Patient activation and conversion

Awareness only matters if it converts. We run social-media-led disease awareness and patient-finding campaigns that route real people towards KOLs and Centres of Excellence.

Get in touch
Person on social media seeing a survey that helps them get treatment

Delivered with a specialist healthcare marketing partner working across Europe, Middle East and Africa, combining paid social, influencer and patient-organisation partnerships.

Campaigns are designed around a defined referral endpoint from day one — a KOL clinic, a Centre of Excellence, a diagnostic pathway — so success is measured in patients reaching care, not impressions.

This is especially effective in rare and underdiagnosed disease, where the patient population is small, dispersed, and already searching online for an explanation.

What we deliver

Disease awareness campaigns

Condition-led social and content campaigns that reach undiagnosed and misdiagnosed patients.

Patient finding

Targeted digital and influencer activity designed to surface patients who fit a specific clinical profile.

Referral into KOLs and Centres of Excellence

Conversion pathways that route interested patients to named specialist centres rather than a dead-end landing page.

Influencer and patient-organisation partnerships

Credible voices — patient advocates and associations — carrying the awareness message.

Patient education and engagement

Multi-week education activities that keep diagnosed patients engaged with their pathway.

EMEA market coverage

Regional expertise across Europe, Middle East and Africa markets, including local-language execution.

Case studies

Scleroderma patient finding via influencer marketing

Context
A pharma client needed to reach undiagnosed scleroderma patients in an EMEA market where the condition is rarely recognised early.
Approach
An influencer-led social awareness campaign built around symptom recognition, driving people toward specialist assessment.
Outcome
15 new scleroderma patients identified in five months, as published by our delivery partner.

Published partner case study (Boehringer Ingelheim scleroderma campaign, grandaliro.com).

Multi-year diabetes patient engagement

Context
A client wanted diagnosed diabetes patients to stay engaged with education and their treatment pathway.
Approach
A sustained patient education programme including a focused 14-day engagement activity across digital channels.
Outcome
An ongoing, multi-year engagement platform rather than a one-off awareness burst.

Published partner case study (Boehringer Ingelheim diabetes programme, grandaliro.com).

Insights when you need them

Tell us the decision you are trying to make and we will tell you honestly whether this is the right route.

Get in touch